Member Exclusive News

Moving CRISPR-based therapies through the clinic

Scientists from Gladstone Institutes (CA, USA), the Innovative Genomics Institute (IGI; CA, USA) and AstraZeneca (Cambridge, UK), have developed a method that can identify potential off-target effects in therapeutically relevant cells when using CRISPR.

Thumb fsg
Apr 23, 2019

Please sign in or register for FREE

No comments yet.